Monoclonal antibody-based quantitation of poly(ethylene glycol)-derivatized proteins, liposomes, and nanoparticles

Tian Lu Cheng, Chiu Min Cheng, Bing Mae Chen, Der An Tsao, Kuo Hsiang Chuang, Sheng Wen Hsiao, Yi Hung Lin, Steve R. Roffler

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Covalent attachment of poly(ethylene glycol) (PEG) molecules to drugs, proteins, and liposomes is a proven technology for improving their bioavailability, safety, and efficacy. Qualitative and quantitative analysis of PEG-derivatized molecules is important for both drug development and clinical applications. We previously reported the development of a monoclonal IgM antibody (AGP3) to PEG. We now describe a new IgG1 monoclonal antibody (E11) to PEG and show that it can be used in combination with AGP3 to detect and quantify PEG-derivatized molecules. Both antibodies bound the repeating subunits of the PEG backbone and could detect free PEG and PEG-modified proteins by ELISA, immunoblotting, and flow cytometry. Detection sensitivity increased with the length and the number of PEG chains on pegylated molecules. Both antibodies also efficiently accelerated the clearance of a PEG-modified enzyme in vivo. A sandwich ELISA in which E11/AGP3 were employed as the capture/detection antibodies was developed to detect PEG-modified proteins at concentrations as low as 1.2 ng/mL. In addition, the ELISA could also quantify, in the presence of 10% fetal bovine serum, free methoxy-PEG 20,000, PEG2,000-quantum dots, and PEG2,000- liposomes at concentrations as low as 20 ng/mL (1.0 nM), 1.4 ng/mL (3.1 pM), and 2.4 ng/mL (3.13 nM phospholipids), respectively. Finally, we show that the sandwich ELISA could accurately measured the in vivo half-life of a PEG-modified enzyme. These antibodies should be generally applicable to the qualitative and quantitative analysis of all PEG-derivatized molecules.

Original languageEnglish
Pages (from-to)1225-1231
Number of pages7
JournalBioconjugate Chemistry
Volume16
Issue number5
DOIs
Publication statusPublished - Sep 2005
Externally publishedYes

Fingerprint

Monoclonal antibodies
Ethylene Glycol
Liposomes
Nanoparticles
Polyethylene glycols
Enzyme-Linked Immunosorbent Assay
Monoclonal Antibodies
Proteins
Antibodies
Quantum Dots
Enzymes
Immunoblotting
Pharmaceutical Preparations
Biological Availability
Immunoglobulin M
Half-Life
Phospholipids
Flow Cytometry
Molecules
Immunoglobulin G

ASJC Scopus subject areas

  • Chemistry(all)
  • Organic Chemistry
  • Clinical Biochemistry
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry

Cite this

Monoclonal antibody-based quantitation of poly(ethylene glycol)-derivatized proteins, liposomes, and nanoparticles. / Cheng, Tian Lu; Cheng, Chiu Min; Chen, Bing Mae; Tsao, Der An; Chuang, Kuo Hsiang; Hsiao, Sheng Wen; Lin, Yi Hung; Roffler, Steve R.

In: Bioconjugate Chemistry, Vol. 16, No. 5, 09.2005, p. 1225-1231.

Research output: Contribution to journalArticle

Cheng, Tian Lu ; Cheng, Chiu Min ; Chen, Bing Mae ; Tsao, Der An ; Chuang, Kuo Hsiang ; Hsiao, Sheng Wen ; Lin, Yi Hung ; Roffler, Steve R. / Monoclonal antibody-based quantitation of poly(ethylene glycol)-derivatized proteins, liposomes, and nanoparticles. In: Bioconjugate Chemistry. 2005 ; Vol. 16, No. 5. pp. 1225-1231.
@article{4bcba53ef9174be48b54e831337c9efa,
title = "Monoclonal antibody-based quantitation of poly(ethylene glycol)-derivatized proteins, liposomes, and nanoparticles",
abstract = "Covalent attachment of poly(ethylene glycol) (PEG) molecules to drugs, proteins, and liposomes is a proven technology for improving their bioavailability, safety, and efficacy. Qualitative and quantitative analysis of PEG-derivatized molecules is important for both drug development and clinical applications. We previously reported the development of a monoclonal IgM antibody (AGP3) to PEG. We now describe a new IgG1 monoclonal antibody (E11) to PEG and show that it can be used in combination with AGP3 to detect and quantify PEG-derivatized molecules. Both antibodies bound the repeating subunits of the PEG backbone and could detect free PEG and PEG-modified proteins by ELISA, immunoblotting, and flow cytometry. Detection sensitivity increased with the length and the number of PEG chains on pegylated molecules. Both antibodies also efficiently accelerated the clearance of a PEG-modified enzyme in vivo. A sandwich ELISA in which E11/AGP3 were employed as the capture/detection antibodies was developed to detect PEG-modified proteins at concentrations as low as 1.2 ng/mL. In addition, the ELISA could also quantify, in the presence of 10{\%} fetal bovine serum, free methoxy-PEG 20,000, PEG2,000-quantum dots, and PEG2,000- liposomes at concentrations as low as 20 ng/mL (1.0 nM), 1.4 ng/mL (3.1 pM), and 2.4 ng/mL (3.13 nM phospholipids), respectively. Finally, we show that the sandwich ELISA could accurately measured the in vivo half-life of a PEG-modified enzyme. These antibodies should be generally applicable to the qualitative and quantitative analysis of all PEG-derivatized molecules.",
author = "Cheng, {Tian Lu} and Cheng, {Chiu Min} and Chen, {Bing Mae} and Tsao, {Der An} and Chuang, {Kuo Hsiang} and Hsiao, {Sheng Wen} and Lin, {Yi Hung} and Roffler, {Steve R.}",
year = "2005",
month = "9",
doi = "10.1021/bc050133f",
language = "English",
volume = "16",
pages = "1225--1231",
journal = "Bioconjugate Chemistry",
issn = "1043-1802",
publisher = "American Chemical Society",
number = "5",

}

TY - JOUR

T1 - Monoclonal antibody-based quantitation of poly(ethylene glycol)-derivatized proteins, liposomes, and nanoparticles

AU - Cheng, Tian Lu

AU - Cheng, Chiu Min

AU - Chen, Bing Mae

AU - Tsao, Der An

AU - Chuang, Kuo Hsiang

AU - Hsiao, Sheng Wen

AU - Lin, Yi Hung

AU - Roffler, Steve R.

PY - 2005/9

Y1 - 2005/9

N2 - Covalent attachment of poly(ethylene glycol) (PEG) molecules to drugs, proteins, and liposomes is a proven technology for improving their bioavailability, safety, and efficacy. Qualitative and quantitative analysis of PEG-derivatized molecules is important for both drug development and clinical applications. We previously reported the development of a monoclonal IgM antibody (AGP3) to PEG. We now describe a new IgG1 monoclonal antibody (E11) to PEG and show that it can be used in combination with AGP3 to detect and quantify PEG-derivatized molecules. Both antibodies bound the repeating subunits of the PEG backbone and could detect free PEG and PEG-modified proteins by ELISA, immunoblotting, and flow cytometry. Detection sensitivity increased with the length and the number of PEG chains on pegylated molecules. Both antibodies also efficiently accelerated the clearance of a PEG-modified enzyme in vivo. A sandwich ELISA in which E11/AGP3 were employed as the capture/detection antibodies was developed to detect PEG-modified proteins at concentrations as low as 1.2 ng/mL. In addition, the ELISA could also quantify, in the presence of 10% fetal bovine serum, free methoxy-PEG 20,000, PEG2,000-quantum dots, and PEG2,000- liposomes at concentrations as low as 20 ng/mL (1.0 nM), 1.4 ng/mL (3.1 pM), and 2.4 ng/mL (3.13 nM phospholipids), respectively. Finally, we show that the sandwich ELISA could accurately measured the in vivo half-life of a PEG-modified enzyme. These antibodies should be generally applicable to the qualitative and quantitative analysis of all PEG-derivatized molecules.

AB - Covalent attachment of poly(ethylene glycol) (PEG) molecules to drugs, proteins, and liposomes is a proven technology for improving their bioavailability, safety, and efficacy. Qualitative and quantitative analysis of PEG-derivatized molecules is important for both drug development and clinical applications. We previously reported the development of a monoclonal IgM antibody (AGP3) to PEG. We now describe a new IgG1 monoclonal antibody (E11) to PEG and show that it can be used in combination with AGP3 to detect and quantify PEG-derivatized molecules. Both antibodies bound the repeating subunits of the PEG backbone and could detect free PEG and PEG-modified proteins by ELISA, immunoblotting, and flow cytometry. Detection sensitivity increased with the length and the number of PEG chains on pegylated molecules. Both antibodies also efficiently accelerated the clearance of a PEG-modified enzyme in vivo. A sandwich ELISA in which E11/AGP3 were employed as the capture/detection antibodies was developed to detect PEG-modified proteins at concentrations as low as 1.2 ng/mL. In addition, the ELISA could also quantify, in the presence of 10% fetal bovine serum, free methoxy-PEG 20,000, PEG2,000-quantum dots, and PEG2,000- liposomes at concentrations as low as 20 ng/mL (1.0 nM), 1.4 ng/mL (3.1 pM), and 2.4 ng/mL (3.13 nM phospholipids), respectively. Finally, we show that the sandwich ELISA could accurately measured the in vivo half-life of a PEG-modified enzyme. These antibodies should be generally applicable to the qualitative and quantitative analysis of all PEG-derivatized molecules.

UR - http://www.scopus.com/inward/record.url?scp=25444477783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25444477783&partnerID=8YFLogxK

U2 - 10.1021/bc050133f

DO - 10.1021/bc050133f

M3 - Article

C2 - 16173802

AN - SCOPUS:25444477783

VL - 16

SP - 1225

EP - 1231

JO - Bioconjugate Chemistry

JF - Bioconjugate Chemistry

SN - 1043-1802

IS - 5

ER -